These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 14129849

  • 1. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL.
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP.
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE.
    LOVSHIN LL.
    Headache; 1963 Oct; 3():107-11. PubMed ID: 14094106
    [No Abstract] [Full Text] [Related]

  • 7. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F.
    Int Arch Allergy Appl Immunol; 1959 Oct; 15():300-7. PubMed ID: 14446408
    [No Abstract] [Full Text] [Related]

  • 8. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F.
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract] [Full Text] [Related]

  • 9. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR, REED AF.
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ, CAMP WA, GOODELL H, WOLFF HG.
    Trans Am Neurol Assoc; 1961 Jan; 86():95-8. PubMed ID: 13883198
    [No Abstract] [Full Text] [Related]

  • 12. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ, CAMP WA, GOODELL H, WOLFF HG.
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [EFFECT OF SOME ANTISEROTONIN DRUGS ON BLOOD COAGULATION].
    BADYDA C, BIELSKI J, CHODERA A, OWCZAREK L.
    Acta Physiol Pol; 1963 Mar; 14():645-52. PubMed ID: 14123361
    [No Abstract] [Full Text] [Related]

  • 15. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F.
    Med Exp Int J Exp Med; 1960 Mar; 2():36-9. PubMed ID: 14446407
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [EFFECT OF LYSENYL, DESERIL AND OTHER SEROTONIN ANTAGONISTS ON BIOCHEMICAL SYSTEMS].
    RYSANEK K, VITEK V.
    Act Nerv Super (Praha); 1963 May; 5():210-1. PubMed ID: 14070658
    [No Abstract] [Full Text] [Related]

  • 18. THE OTOLARYNGOLOGIST AND THE COMMON HEADACHE SYNDROMES.
    OSTFELD AM.
    Trans Am Acad Ophthalmol Otolaryngol; 1963 May; 67():766-9. PubMed ID: 14082486
    [No Abstract] [Full Text] [Related]

  • 19. INCREASE IN ANTI-5HT ACTIVITY BY L-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS.
    YUI T, TAKEO Y.
    Jpn J Pharmacol; 1964 Mar; 14():107-8. PubMed ID: 14167727
    [No Abstract] [Full Text] [Related]

  • 20. METHYSERGIDE (SANSERT) IN THE PREVENTION OF MIGRAINE: A CLINICAL TRIAL.
    LLOYD-SMITH DL, MCNAUGHTON FL.
    Can Med Assoc J; 1963 Dec 14; 89(24):1221-3. PubMed ID: 14084702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.